Suppose technically this should fall under this thread.
JNJ has been hammering on about its success of its autologous (CAR T-Cell) cellular therapy in last nights earnings:
"This includes the launches of CARVYKTI, our first cell therapy....[in] MedTech, we generated above 6% full year operational growth, anticipating our second consecutive year outperforming our competitive composite."
Cellular therapies are a focused growth area for JNJ. Margins in the sector rose from 18% to 25% on strong demand in areas that have unmet needs:
"As far as the demand for CARVYKTI, we see very strong demand for CARVYKTI....There’s a significant need for new therapies in this relapsed/refractory patient population....the demand....really encouraging and pertains the unmet medical need for these types of patients."
I would be first to admit that no way a partnership with JNJ in OrthoATI is assured for OCC, but given the success of JNJ/OCC (above) in their OrthoATI phase II trial and now the strong demand, growth and margins JNJ is anticipating for Carvykti (a cellular therapy that holds many analogies with OrthoATI), I would be really surprised if something does not eventuate.
- Forums
- ASX - By Stock
- OCC
- Ann: OrthoATI Tendon Clinical Study Success
Ann: OrthoATI Tendon Clinical Study Success, page-241
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $83.83M |
Open | High | Low | Value | Volume |
39.0¢ | 40.0¢ | 39.0¢ | $199.1K | 504.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3807 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 3666 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3807 | 0.390 |
2 | 7793 | 0.385 |
3 | 27634 | 0.380 |
2 | 42700 | 0.375 |
4 | 23903 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 3666 | 2 |
0.405 | 74300 | 2 |
0.410 | 45237 | 4 |
0.420 | 135239 | 3 |
0.425 | 39350 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |